Phenominer Database Results (18 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
COP liver remodeling tumorous lesion number to liver total tumorous lesion number ratio N-nitrosodiethylamine (150 mg/kg) then controlled protein content diet (for 15 days) and 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy (for 202.5 days) De Miglio MR, et al., Int J Cancer 2004 Aug 10;111(1):9-16. liver integrity trait male  days 10 83.0 % ex vivo light microscopy with digital image analysis liver 0.0 224 days 70203 1302
F344/NRrrc liver remodeling tumorous lesion number to liver total tumorous lesion number ratio N-nitrosodiethylamine (150 mg/kg) then controlled protein content diet (for 15 days) and 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy (for 202.5 days) De Miglio MR, et al., Int J Cancer 2004 Aug 10;111(1):9-16. liver integrity trait male  days 10 19.0 % ex vivo light microscopy with digital image analysis liver 0.0 224 days 70204 1302
F344/NHsd liver tumorous lesion number N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 12 126820.0 null 9698.0 33594.86 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine 224 days CMO:0001068 68349 912
F344/NHsd volume of liver occupied by tumorous lesions as percentage of total liver volume N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 12 84.18 % 3.64 12.61 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine 224 days 68353 912
BN/Crli volume of liver occupied by tumorous lesions as percentage of total liver volume N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. liver integrity trait not specified  days 20 13.69 % 1.99 8.9 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection 224 days 150mg/Kg body weight 67758 789
BN/SsNHsd percentage of study population developing hepatocellular carcinoma during a period of time N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 490 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 10 10.0 % necropsy 0.0 N-nitrosodiethylamine 490 days CMO:0001068 96758 912
BN/SsNHsd volume of liver occupied by tumorous lesions as percentage of total liver volume N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 7 19.83 % 2.09 5.53 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine 224 days 68354 912
F344/NHsd hepatocellular carcinoma tumor number N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 mg/kg) (for 490 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 9 3.5 null 0.23 0.69 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine 490 days 68391 912
F344/Crli volume of individual liver tumorous lesion N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. liver integrity trait not specified  days 20 3.26 cm3 x 10000 0.33 1.48 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection 224 days 150mg/Kg body weight 67731 789
BN/SsNHsd volume of individual liver tumorous lesion N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 7 0.12 cm3 x 10000 0.03 0.07 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine 224 days 68352 912
BN/SsNHsd hepatocellular carcinoma tumor number N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 mg/kg) (for 210 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 10 1.3 null 0.13 0.41 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine 490 days 68389 912
F344/Crli liver tumorous lesion number to liver volume ratio N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. liver integrity trait not specified  days 20 7875.0 /cm3 624.0 2790.61 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection 224 days 150mg/Kg body weight need to update double congenicstrain 67713 789
BN/Crli volume of individual liver tumorous lesion N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. liver integrity trait not specified  days 20 0.09 cm3 x 10000 0.02 0.09 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection 224 days 150mg/Kg body weight 67736 789
F344/Crli volume of liver occupied by tumorous lesions as percentage of total liver volume N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. liver integrity trait not specified  days 20 80.11 % 6.33 28.32 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection 224 days 150mg/Kg body weight 67755 789
F344/NHsd percentage of study population developing hepatocellular carcinoma during a period of time N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 490 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 9 89.0 % necropsy 0.0 N-nitrosodiethylamine 490 days CMO:0001068 96757 912
BN/SsNHsd liver tumorous lesion number N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 7 155800.0 null 19408.0 51348.74 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine 224 days CMO:0001068 68350 912
F344/NHsd volume of individual liver tumorous lesion N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. liver integrity trait not specified  days 12 2.95 cm3 x 10000 0.35 312.98 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine 224 days 68351 912
BN/Crli liver tumorous lesion number to liver volume ratio N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. liver integrity trait not specified  days 20 11142.0 /cm3 930.0 4159.09 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection 224 days 150mg/Kg body weight update term and unit 67721 789